Key facts
- It has raised $2.9M; the latest was Seed Round ($2.9M) in Apr 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Fusu Life Science Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Fusu Life Science Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fusu Life Science Technology
Provider of a life science research service intended to support biological discovery and translational research. The company offers integrated experimental tools, data-driven research workflows, and laboratory support, enabling academic and industrial life science researchers to conduct rigorous studies with reproducible, reliable outcomes.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2026
- Ownership
- Privately Held (backing)
Fusu Life Science Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fusu Life Science Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fusu Life Science Technology in its N-PORT filings yet. We sweep new filings monthly.